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Abstract
Survival prediction with small sets of features is a highly relevant topic for decision-
making in clinical practice. I describe a method for predicting survival of amy-
otrophic lateral sclerosis (ALS) patients that was developed as a submission to
the DREAM ALS Stratification Prize4Life Challenge held in summer 2015 to
find the most accurate prediction of ALS progression and survival. ALS is a neu-
rodegenerative disease with very heterogeneous survival times. Based on patient
data from two national registries, solvers were asked to predict survival for three
different time intervals, which was then evaluated on undisclosed information from
additional data.
I describe methods used to generate new features from existing ones from longitu-
dinal data, selecting the most predictive features, and developing the best survival
model. I show that easily obtainable engineered features can significantly improve
prediction and could be incorporated into clinical practice. Furthermore, my pre-
diction model confirms previous reports suggesting that past disease progression
measured by the ALSFRS (ALS functional rating scale score), time since disease
onset, onset site, and age are strong predictors for survival. Regarding prediction
accuracy, this approach ranked second.
1 Introduction
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s syndrome or Motor Neuron
Disease, is an incurable degenerative disease of the motor nervous system: it involves progressive
and irreversible damage or degeneration of nerve cells (neurons) responsible for muscle movements.
Symptoms include speech and swallowing disorders, impaired coordination, and weakness of the
arm and hand muscles leading to progressive reduction in the activities of daily living and eventually
death. The site of disease onset as experienced by the patient can be a limb ("limb onset") or the
muscles controlling speaking and swallowing ("bulbar onset"), or occasionally both. ALS is a rare
disease with a prevalence of 3-8 per 100,000. The median survival in ALS from first symptom ranges
from 2 to 4 years (Czaplinski et al. [2006]), but a proportion of patients survive more than 10 years
(Prof. Stephen Hawking being the most prominent example). This heterogeneity of ALS outcomes
makes survival difficult to predict (Louwerse et al. [1997], Gordon et al. [2013]).
To improve prediction a new computational community challenge has been presented within the
Dialogue on Reverse Engineering Assessment and Methods (DREAM) project (Stolovitzky et al.
[2007]). The DREAM ALS Stratification Prize4Life Challenge 2015 (hereafter referred to as "the
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challenge") is a follow-up to the DREAM Phil Bowen ALS Prediction Prize4Life Challenge (Küffner
et al. [2015]) with the aim of finding predictors of disease progression that can be used to aid clinical
care, identify new disease predictors, and potentially significantly reduce the costs of future ALS
clinical trials.
The challenge provided two different data sets from different trials and registries, and participants
were asked to predict survival, given as probability of death, for three time points. A restricting part
of the challenge was to use only six variables from the data set provided.
In this paper, I present my approach to feature engineering, feature selection, and the survival model.
2 Materials and Methods
Data description
Data sources are the PROACT (Pooled Resource Open-Access ALS Clinical Trials) clinical trial
database (PROACT [2015]) and a mix of two national registries (NatReg). All data were collected
between 1990 and 2015. The PROACT database provides a training set of N = 7200 patients,
combined from an unknown number of publicly and privately conducted ALS clinical trials; the
registries contain N = 986 patients from two national registries, Italy and Ireland. Algorithms will
be evaluated on data (N = 1900) from six new trials not yet available in PROACT, which may
contain variables dissimilar to the training set. Therefore, an additional set of N = 200 records
from this validation set was provided. Additionally, a set of N = 493 patients from the NatReg set
was withheld for validation. Both PROACT and NatReg data sets provide a variety of baseline and
longitudinal values, such as laboratory measures, medication, and vital status. Overall, more than
100 variables were available. According to the organizers, this is the largest data set ever used for the
prediction of ALS progression and survival.
Data cleaning and feature engineering
Based on the longitudinal data from the 0–3 months period, I generated new variables for each of the
original longitudinal variables. Table 1 presents an overview. Note that some of these new variables
are highly correlated, e.g., if there is only one observation for a patient, then mean, max, min, first,
and last will be the same value, while sd, diff, minmax and slope will be set to zero. I therefore chose
to delete variables with a Pearson correlation coeffiecient of ρ > 0.95.
Table 1: Description of all additional variables that were generated from each longitudinal
variable.
Variable suffix Description
mean The mean of all values in the 0–3 months period
sd The standard deviation of all values in the 0-3 months period
max The maximum value in the 0–3 months period
min The minimum value in the 0–3 months period
diff The difference between the maximum and the minimum values
first The first observed value in the 0–3 months period
last The last observed value in the 0–3 months period
len The number of observed values in the 0–3 months period
minmax The slope of the max and min regression line
slope The slope of the regression line in the 0–3 months period
Feature selection
Even after removing those variables with ρ > 0.95, some of the variables are still highly correlated; for
example, the hand and leg items from the ALSFRS score are strongly related. Therefore, traditional
stepwise elimination approaches are not efficient (Hastie et al. [2005]). I based variable selection
on three different algorithms: random forest variable importance, gradient boosting, and elastic net
regularization. Both boosting and elastic net regularization are built upon a Cox proportional hazards
(PH) model.
2
Survival model
To find the best survival model for my data, I compared five different algorithms in a 5-fold cross-
validation setting:
1. Recusive partitioning for survival trees (RPART), as described in the book by
Breiman (Breiman et al. [1984]) and implemented in the rpart package.
2. The random survival forest (RSF) approach illustrated by Ishwaran et al (Ishwaran et al.
[2008]) and implemented in the accompanying R package randomForestSRC.
3. The Cox PH model, implemented in the survival package (Therneau [2015]).
4. A Cox PH model with Elastic Net regularization, implemented in the glmnet package (Fried-
man et al. [2010], Simon et al. [2011]).
5. A gradient boosted Cox model, implemented in the CoxBoost package.
3 Results and Discussion
RPART
Random Surv. Forest
Cox PH
Cox Elastic Net
Cox Boost
Figure 1: (A) Variable importance plots for the 10 most important variables in all three models. (B)
Cross-validation results of the survival model comparison. Bars represent the lower and upper limits
of c-index in the folds; black dot is the mean c-index across all folds. (C) Variable importance plots
for the final model.
Selected variables
Fig 1 (A) shows the variable importance plots of all three models. Variables generated by the
alsfrs feature have the greatest importance in all three methods. respiratory (the score for
the respiratory item in the ALSFRS) variables are regarded as of almost equally high importance,
whereas onset_delta (the time since disease onset in days) was only chosen by random forest
and boosting. The other variables I included in the model were mouth (the score for the mouth
item in the ALSFRS), Age (baseline age of each patient), and onset_site (site of disease onset).
According to the literature (Kollewe et al. [2008]), the forced vital capacity is a predictive feature for
survival. However, it could not be used in the model because of its large number of missing values.
Interestingly, the team that was placed first in the challenge selected exactly the same variables.
3
Survival model
For the final model, I chose RSF as it showed the best performance in the cross-validation. One
advantage of RSF is that it does not expect linear features or even features that interact linearly.
It is robust to outliers and can handle missing values. Furthermore, RSF works very well with
large numbers of observations and has a natural way of dealing with data of mixed type (e.g.,
categorial variables, count variables, or binary variables). Fig 1 (B) shows the cross-validation model
comparison.
Variable importance
The 12 most important variables in the final model are depicted in Fig 1 (C). Except for the baseline
variables onset_delta and Age, all other variables are engineered. The time of disease onset
(onset_delta) is by far the most important variable because early onset corresponds with slow
progression and therefore increased survival. The difference between the maximum and minimum
measured ALSFRS score in the 0–3 months period (alsfrs_diff) is considered to be the second
most important variable. This feature covers those patients with rapid degeneration in the first 3
months, but it cannot detect patients who recover in this period as it does not include the time points
of the measurement. Interestingly, it is still slightly favored over alsfrs_slope, which measures
the slope of the ALSFRS linear regression line and can thus cover patients whose health improved.
I speculate that the combination of both leads to improved predictions, and this is well handled in
the arms of the decision trees. For example, positive slope and large difference mean rapid recovery,
whereas negative slope and large difference result in rapid degeneration. Other highly important
features such as the last (alsfrs_last) and the smallest (alsfrs_min) measured ALSFRS score
make sense intuitively. The site of disease onset (onset_site) is not among the most important
predictors, but again may play a role in combination with other variables.
4 Conclusion
In this article, I have described the approach that was placed second in the DREAM ALS Stratification
challenge. I have shown how feature engineering can be used when limited data are available in
longitudinal form. New features generated from existing variables can be more predictive than others
already at hand. The generated features can easily be incorporated into a clinical setting. I have
also shown that variable selection should be examined by a variety of methods, as each method can
produce different results. I have explained my choice of the final survival model.
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